GWAS of Second-Generation Antihistamine Use: Locus Specificity and Highlighted Signaling Pathways

Authors:
  • VÄVähätalo
    Vähätalo
  • FGFinn Gen
    Finn Gen

Abstract
Background Second-generation H 1 -antagonists are widely used to treat multiple allergic and non-allergic chronic conditions. Aims We aimed to identify genetic loci, locus specificity, and enriched signaling pathways associated with long-term systemic second-generation antihistamine (sgAH) use in the context of underlying diseases. Materials and Methods In FinnGen, 38,645 individuals with ≥10 sgAH purchases from Finnish pharmacies were identified, while 201,334 individuals with no such purchases served as controls. Comprehensive drug purchase records and clinical diagnoses were retrieved from national registries. Genome-wide association analysis (GWAS) of sgAH use was conducted using Regenie (17 million genotyped and imputed variants). MAGMA was employed for gene and pathway-level enrichment analysis, and phenotypic specificity of associations was evaluated using MetABF. Results In GWAS for sgAH use, we identified 67 independent loci at genome wide significance (P-8 ). Four of identified loci (near DELEC1/TNFSF8, POU2AF1, RNY1P8/KLF5, and LINC00334/POFUT2 ) were specific for sgAH use. The remaining loci also demonstrated genome-wide significant associations with conditions such as asthma, chronic rhinitis, conjunctivitis, atopic eczema, sinusitis, and urticaria, all of which are indicative of sgAH use. Missense variants were observed in IL6RA , IL4RA , TESPA1 , C17orf58, and one lost-of-function mutation in FLG . The TESPA1 variant lies in a conserved region, suggesting potential structural impact. MAGMA analysis revealed significant associations with four gene sets, including IL-2 family cytokines (P=5.0×10 -9 ). Conclusions Most loci associated with sgAH use overlap with those implicated in the underlying, immune mediated diseases. Independent of diagnosis, IL-2 family cytokines signaling via the common γ-chain and the JAK–STAT pathway is significantly enriched among long-term sgAH users.